Depression and Anxiety Trial, Recruiting NCT07413692 Sponsor: BTL Industries Ltd. Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07413692
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You gave birth to one healthy baby between 2 and 60 months before joining the study
  • You are currently involved in caring for, or regularly spending time with, that child
  • You scored 5 or higher on a standard depression questionnaire called the PHQ-9
  • You are between 22 and 60 years old
  • The study team is able to measure a specific response in your hand muscles to confirm the treatment can be safely set up for you (confirm with trial site)
  • You are willing to avoid other treatments for depression or bladder leakage — including other brain stimulation therapies — while taking part in the study
  • You are willing to follow all study instructions and attend all required clinic visits
  • If there is any reasonable chance you could become pregnant during the study, you are willing to use birth control throughout
  • If you are already taking psychiatric medications or receiving talk therapy, you have been on a stable dose or routine for at least 1 month before joining (if applicable)

Who may not be able to join:

  • You have any metal objects in or near your head, such as implanted electrodes, aneurysm clips, stents, or bullet fragments (note: standard dental fillings, single dental implants, bridgework, and braces may still be acceptable — confirm with trial site)
  • You have any implanted devices such as a deep brain stimulator, cochlear implant, eye implant, or vagus nerve stimulator
  • You have a cardiac pacemaker or implanted defibrillator
  • You have any other electronic or metal implants in your body
  • You have a drug pump implanted in your body
  • You have a condition or history that makes you prone to seizures, such as epilepsy or low muscle tone (hypotonia)
  • You are currently taking blood-thinning (anticoagulation) medication
  • You have a severe or life-threatening illness
  • You have a serious lung condition affecting your breathing
  • You have a heart condition
  • You have a serious kidney condition
  • You have an uncontrolled bleeding disorder, blood clotting disorder, or cardiovascular disease that requires long-term medication (confirm with trial site)
  • You have been diagnosed with any type of tumour, whether cancerous or non-cancerous
  • You currently have a fever
  • You are pregnant
  • You are currently having thoughts of suicide or have attempted suicide in the last 3 years
  • Your depression is caused by substance use or by another medical condition
  • You have been diagnosed with seasonal affective disorder, a psychotic disorder, schizoaffective disorder, bipolar disorder, borderline personality disorder, or major depression with psychotic features
  • You are currently misusing substances or were dependent on substances within the 3 months before joining the study
  • You have previously had, or are currently receiving, electroconvulsive therapy (ECT) or vagus nerve stimulation
  • You have a neurological condition such as a history of seizures, stroke, brain tumour, brain aneurysm, dementia, or a movement disorder
  • You have a history of increased pressure in the brain or a significant head injury
  • You have any other medical condition or situation that the study doctor believes could put you at risk or affect the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
BTL Industries Ltd.
Registry
ClinicalTrials.gov
Start date
25 November 2025
Est. completion
11 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Assessment of Change in Self-Reported Symptoms of Depression in Postpartum Women and in Women up to Five Years after Childbirth

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov